TScan Therapeutics Inc (NAS:TCRX)
$ 0.36 -0.30 (-45.6%) Market Cap: 24.54 Mil Enterprise Value: 15.28 Mil PE Ratio: 0 PB Ratio: 0.35 GF Score: 40/100

TScan Therapeutics Inc Virtual KOL Event Transcript

Dec 8, 2025 / 01:00 PM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TCRX.OQ - TScan Therapeutics Inc
TScan Therapeutics Inc Virtual KOL Event
Dec 08, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
KL call. We ask that you please hold off, at which time you will be given instructions for the question-and-answer session. Also, as a reminder, this conference is being recorded. If you have any objections, please disconnect at this time.

With that, I would like to turn the call over to Gavin McBeef, PhD, Chief Executive Officer. Mr. McBeth, you may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you and thank you everyone for joining us this morning. So we are excited to be here to present our updated data that we presented at the American Society of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot